News

Press Releases

• GenomeQuest and Questel Partner on IP Platform Integration
• GQ-Dx 2.0 Helps Laboratories Deliver Fast, Accurate, and Actionable NGS Diagnostics to the Clinic
• Six Innovative Laboratories Win GenomeQuest Grants to Bring Next Generation Sequencing Diagnostics to the Clinic
• GenomeQuest Forms Clinical Advisory Board
• GenomeQuest CEO Richard Resnick Participates in Panel on Genomics in Clinical Trials at NGX 2011
• GenomeQuest and Pathogenica Partner to Offer Genome-based Infectious Disease Discovery Services
• GenomeQuest Announces University of Iowa Researchers Select GQ-Dx Decision Support System to Offer Consolidated Molecular Test for Inherited Deafness
• GenomeQuest Unveils Industry’s First Clinical Decision-Support System to Translate Advances from Whole-Genome Sequencing to Personalized Medicine
• Gerry A. Higgins, Ph.D. Joins GenomeQuest to Foster Development of Whole Genome Diagnostics
• GenomeQuest to Lead Biomarker World Congress Panel on Applying Whole Genome Sequencing to Developing Companion Diagnostics

Coverage

• GenomeQuest and Questel Partner on IP Platform Integration
• Richard Resnick: “The prospect of using the genome as a universal diagnostic is upon us.” -MedGadget
• GenomeQuest Snags Emory as Latest Lab to Use GQ-Dx for NGS Diagnostics; Eyes Dx Partnerships -GenomeWeb
• The $999 Genome Is Less Important Than What We Do With It -FastCompany
• Mutation discovery in mice by whole exome sequencing -Genome Biology
• GenomeQuest Provides Software, Services to Six Labs Switching from Sanger- to NGS-Based Gene Tests -GenomeWeb
• Downloads and Upgrades - GenomeWeb
• GenomeQuest Awards $120K in Grants to Support NGS-Based Diagnostics -Genetic Engineering & Biotechnology News
• Richard Resnick’s Quest for Genome Governance -Bio-IT World
• Bringing Genetic Data into the Clinic -PharmExec